The purpose of the present study was to evaluate whether human insulin use without confounding exposure to insulin analogs would increase the risk of breast cancer in female patients with type 2 diabetes mellitus, by using the National Health Insurance (NHI) databases of Taiwan. This evidence concerns the gene INS and type 2 diabetes mellitus.